Sotera Health Company (SHC) Stock Score, Valuation & Financial Research
Sotera Health Company is in the Healthcare sector and Medical - Diagnostics & Research industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. The current Wall Street Score is 30/100.
Quick answer for SHC
Sotera Health Company currently has a Wall Street Score of 30/100. The stored market price is $18.37. Its financial score is 29/100. Its valuation score is 0/100. These figures are a research snapshot, not a buy or sell recommendation.
What Sotera Health Company does
Sotera Health Company, headquartered in Broadview Heights, Ohio, delivers essential sterilization, laboratory testing, and advisory services to a global clientele spanning North America, Europe, and various international regions. The firm's sterilization capabilities encompass gamma and electron beam irradiation, alongside ethylene oxide (EO) processing. Through its Nelson Labs division, Sotera Health conducts comprehensive microbiological and analytical chemistry analyses. Additionally, it offers specialized consulting to the medical device and biopharmaceutical industries. Sotera Health serves a diverse array of sectors, including medical device manufacturers, pharmaceutical companies, producers of food and agricultural products, and various commercial, advanced, and specialty application industries. Incorporated in 2017, the company was previously known as Sotera Health Topco, Inc., a
SHC financial snapshot
- Wall Street Score:
- 30/100
- Current price:
- $18.37
- Market capitalization:
- $5.24B
- Revenue:
- $1.19B
- Net income:
- $117.8M
- Free cash flow:
- $149.2M
- Cash:
- $315.9M
- Total debt:
- $2.27B
- EPS:
- 0.27
- P/E ratio:
- 68.0x
- Financial score:
- 29/100
- Valuation score:
- 0/100
- Revenue score:
- 15/100
What stands out
- Reported year-over-year revenue growth is +0.0%.
- Free cash flow is $149.2M, showing positive cash generation.
- The balance sheet shows $315.9M of cash versus $2.27B of total debt, so leverage deserves attention.
What the numbers mean
Its current valuation score is 0/100, which Wall Street Score classifies as weak within the model's valuation framework.
The financial score is 29/100. This is a starting point for reviewing liquidity, leverage and cash-flow strength rather than a stand-alone recommendation.
A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.
Data freshness: Financial data last refreshed 2026-07-24.
How to research SHC
Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.
Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks
Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.